A bathroom remodel can improve your day-to-day routine and bring a fresh, even luxurious, look into your home. This pricing guide explains the cost of a shower remodel and how different factors ...

The bathroom hardware ... shower doors are an ideal way to add a sleek, finished look to your walk-in shower, but they come with an additional cost. Depending on the size and type of glass door ...

My wife and I installed a BASCO sliding shower door a few years ago. It looked beautiful and closed very nicely. Now I need to replace 2 small and inexpensive parts. I called BASCO to order the ...

In contrast, a combination tub-and-shower replacement will generally run around $3,000, and a walk-in shower will cost between $1,000 and $15,000 (plus plumbing and hardware). Depending on the ...

We hate to break it to you, but cloudy shower doors are a sign that you ... Use the sponge to gently scrub stubborn spots, then the whole door. Wipe clean with the microfiber cloth.

Apple’s stock has been under pressure lately ... pace of growth as analysts predict March quarter sales will fall 4.3% from the year earlier. Apple has abandoned its decade-long effort to ...

To get to these levels from the current intraday share price of $178, Apple stock would need to climb a mere 2.8%. For instance, shares jumped 3% on March 15 alone. Therefore, the stock could be ...

The stock market can be a very difficult place for beginners to navigate. Before you start investing your money, you should have a fairly good understanding of how the stock market works.

The Trump stock’s gain was just the fourth in 14 sessions. Through Tuesday, the stock had plunged 54.3% since the merger closed, and had plummeted 65.5% since it closed at a postmerger high of $ ...

The S&P 500 has added 6.1% this year and is off a mere 3.7% from its all-time high, set March 28. Stocks have marched higher since 10-year government-bond yields peaked at 5% in late October.

Zoetis Inc.’s stock ZTS, +1.51% tumbled 7% Friday to lead ... of adverse events with only 0.18% reported for Librela and 0.3% for Solensia, with no unusual trends in safety and efficacy ...